Skip to main content

Table 1 Comparison of autosomal-dominant Alzheimer's disease with sporadic Alzheimer's disease

From: Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease

Measure

ADAD findings

SAD findings

Clinical presentation

Episodic (recent) memory and judgment impairment in most; seizures and myoclonus not rare

Episodic (recent) memory and judgment impairment in most; seizures rare in early disease, more common in late disease

Atypical presentation

Yes - behavioral presentations; spastic paraparesis

Yes - behavioral and language presentations; posterior cortical atrophy

Age of onset

< 60 years for most, can be as early as mid-20s;

> 60 years rarely reported

> 60 years for most; <50 years rarely reported

Duration of illness

Average 6 to 9 years

Average 7 to 10 years

Atrophy - volumetric MRI

Hippocampal atrophy, temporo-parietal cortical loss

Hippocampal atrophy, temporo-parietal cortical loss

Hypometabolism - FDG-PET

Temporo-parietal hypometabolism

Temporo-parietal hypometabolism

Amyloid imaging - PiB-PET

Precuneus/posterior cingulate and prefrontal; consistent striatal binding

Precuneus/posterior cingulate and prefrontal; less consistent striatal binding

Pathology

Plaques and tangles in all; CAA in most; cottonwool plaques in some

Plaques and tangles in all; CAA in most

CSF Aβ42

Decreased

Decreased

CSF tau, p-tau181

Increased

Increased

Blood Aβ42/Aβ40 ratio

Increased

Variable

  1. Aβ, amyloid-beta; ADAD, autosomal-dominant Alzheimer's disease; CAA, cerebral amyloid angiopathy; CSF, cerebrospinal fluid; FDG, fluorodeoxyglucose; MRI, magnetic resonance imaging; PET, positron emission tomography; PiB, Pittsburgh Compound B; SAD, sporadic Alzheimer's disease.